Evotec SE (EVO) Acquisitions (2009 - 2010)
Evotec SE (EVO) posted Acquisitions of $3025.2 for Q2 2010, down 7.93% sequentially from $3285.9 in Q1 2010.
Evotec SE (EVO) Acquisitions (2009 - 2010) Analysis & Trends
Evotec SE has reported Acquisitions for 2 years, with the latest figure at $3025.2 in Q2 2010.
- Quarterly Acquisitions changed N/A year-over-year to $3025.2 in Q2 2010, while the trailing twelve-month figure through Jun 2010 was $3025.2 (changed N/A YoY) and the FY2009 annual result came in at $219007.1, changed N/A from the prior year.
- Acquisitions slipped to $3025.2 in Q2 2010 per EVO's latest filing, from $3285.9 in the prior quarter.
- Over five years, Acquisitions peaked at $231615.4 in Q4 2009 and troughed at -$193.44 in Q3 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.03 Bn | 43.06 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.97 Bn | 39.31 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.63 Bn | 29.95 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.54 Bn | 22.74 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.80 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - | - |
| 10 | Evotec SE | 700.45 Mn | 699.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2010 | 3,025.19 |
| Mar 31, 2010 | 3,285.92 |
| Dec 31, 2009 | 231,615.43 |
| Aug 31, 2009 | -193.44 |